Research

Hormonal

A significant proportion of patients subscribe to digital weight-loss services primarily to access GLP-1 receptor agonist (GLP-1 RA) medications after failing stand-alone lifestyle interventions, supporting the critique that some DWLSs function primarily as medication access pathways.

If you have tried diet and exercise without success, you are not alone. Digital services that offer GLP-1 medications may be a viable option, but ensure they provide medical supervision and are not just a direct-to-consumer pharmacy.

ModerateQualifiesMEDIUM confidence
Many patients (43.7%) expressed their frustration at not being able to lose a meaningful amount of weight through previous attempts at stand-alone diet and exercise regimes. In such cases, it can be reasonably assumed that the Eucalyptus DWLS appeal lay mainly in its provision of GLP-1 RA medications.
Louis Talay et al. · Telemedicine Reports · 2024

Why this rating

Qualitative study of motivations; does not measure clinical outcomes.

Source

Why People with Overweight and Obesity Are Seeking Care Through Digital Obesity Services: A Qualitative Analysis of Patients from Australia’s Largest Digital Obesity Provider

Louis Talay et al. · Telemedicine Reports · 2024

DOI 10.1089/tmr.2024.0031

cohort · n=197Cited 10×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →